Cargando…

ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia

Additional sex combs-like (ASXL) proteins are mammalian homologues of additional sex combs (Asx), a regulator of trithorax and polycomb function in Drosophila. While there has been great interest in ASXL1 due to its frequent mutation in leukemia, little is known about its paralog ASXL2, which is fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Micol, Jean-Baptiste, Pastore, Alessandro, Inoue, Daichi, Duployez, Nicolas, Kim, Eunhee, Lee, Stanley Chun-Wei, Durham, Benjamin H., Chung, Young Rock, Cho, Hana, Zhang, Xiao Jing, Yoshimi, Akihide, Krivtsov, Andrei, Koche, Richard, Solary, Eric, Sinha, Amit, Preudhomme, Claude, Abdel-Wahab, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454368/
https://www.ncbi.nlm.nih.gov/pubmed/28516957
http://dx.doi.org/10.1038/ncomms15429
_version_ 1783240818180489216
author Micol, Jean-Baptiste
Pastore, Alessandro
Inoue, Daichi
Duployez, Nicolas
Kim, Eunhee
Lee, Stanley Chun-Wei
Durham, Benjamin H.
Chung, Young Rock
Cho, Hana
Zhang, Xiao Jing
Yoshimi, Akihide
Krivtsov, Andrei
Koche, Richard
Solary, Eric
Sinha, Amit
Preudhomme, Claude
Abdel-Wahab, Omar
author_facet Micol, Jean-Baptiste
Pastore, Alessandro
Inoue, Daichi
Duployez, Nicolas
Kim, Eunhee
Lee, Stanley Chun-Wei
Durham, Benjamin H.
Chung, Young Rock
Cho, Hana
Zhang, Xiao Jing
Yoshimi, Akihide
Krivtsov, Andrei
Koche, Richard
Solary, Eric
Sinha, Amit
Preudhomme, Claude
Abdel-Wahab, Omar
author_sort Micol, Jean-Baptiste
collection PubMed
description Additional sex combs-like (ASXL) proteins are mammalian homologues of additional sex combs (Asx), a regulator of trithorax and polycomb function in Drosophila. While there has been great interest in ASXL1 due to its frequent mutation in leukemia, little is known about its paralog ASXL2, which is frequently mutated in acute myeloid leukemia patients bearing the RUNX1-RUNX1T1 (AML1-ETO) fusion. Here we report that ASXL2 is required for normal haematopoiesis with distinct, non-overlapping effects from ASXL1 and acts as a haploinsufficient tumour suppressor. While Asxl2 was required for normal haematopoietic stem cell self-renewal, Asxl2 loss promoted AML1-ETO leukemogenesis. Moreover, ASXL2 target genes strongly overlapped with those of RUNX1 and AML1-ETO and ASXL2 loss was associated with increased chromatin accessibility at putative enhancers of key leukemogenic loci. These data reveal that Asxl2 is a critical regulator of haematopoiesis and mediates transcriptional effects that promote leukemogenesis driven by AML1-ETO.
format Online
Article
Text
id pubmed-5454368
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-54543682017-06-07 ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia Micol, Jean-Baptiste Pastore, Alessandro Inoue, Daichi Duployez, Nicolas Kim, Eunhee Lee, Stanley Chun-Wei Durham, Benjamin H. Chung, Young Rock Cho, Hana Zhang, Xiao Jing Yoshimi, Akihide Krivtsov, Andrei Koche, Richard Solary, Eric Sinha, Amit Preudhomme, Claude Abdel-Wahab, Omar Nat Commun Article Additional sex combs-like (ASXL) proteins are mammalian homologues of additional sex combs (Asx), a regulator of trithorax and polycomb function in Drosophila. While there has been great interest in ASXL1 due to its frequent mutation in leukemia, little is known about its paralog ASXL2, which is frequently mutated in acute myeloid leukemia patients bearing the RUNX1-RUNX1T1 (AML1-ETO) fusion. Here we report that ASXL2 is required for normal haematopoiesis with distinct, non-overlapping effects from ASXL1 and acts as a haploinsufficient tumour suppressor. While Asxl2 was required for normal haematopoietic stem cell self-renewal, Asxl2 loss promoted AML1-ETO leukemogenesis. Moreover, ASXL2 target genes strongly overlapped with those of RUNX1 and AML1-ETO and ASXL2 loss was associated with increased chromatin accessibility at putative enhancers of key leukemogenic loci. These data reveal that Asxl2 is a critical regulator of haematopoiesis and mediates transcriptional effects that promote leukemogenesis driven by AML1-ETO. Nature Publishing Group 2017-05-18 /pmc/articles/PMC5454368/ /pubmed/28516957 http://dx.doi.org/10.1038/ncomms15429 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Micol, Jean-Baptiste
Pastore, Alessandro
Inoue, Daichi
Duployez, Nicolas
Kim, Eunhee
Lee, Stanley Chun-Wei
Durham, Benjamin H.
Chung, Young Rock
Cho, Hana
Zhang, Xiao Jing
Yoshimi, Akihide
Krivtsov, Andrei
Koche, Richard
Solary, Eric
Sinha, Amit
Preudhomme, Claude
Abdel-Wahab, Omar
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
title ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
title_full ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
title_fullStr ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
title_full_unstemmed ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
title_short ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
title_sort asxl2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454368/
https://www.ncbi.nlm.nih.gov/pubmed/28516957
http://dx.doi.org/10.1038/ncomms15429
work_keys_str_mv AT micoljeanbaptiste asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT pastorealessandro asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT inouedaichi asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT duployeznicolas asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT kimeunhee asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT leestanleychunwei asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT durhambenjaminh asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT chungyoungrock asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT chohana asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT zhangxiaojing asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT yoshimiakihide asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT krivtsovandrei asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT kocherichard asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT solaryeric asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT sinhaamit asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT preudhommeclaude asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT abdelwahabomar asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia